These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7781125)

  • 1. [Oscillatory potentials in retinitis pigmentosa with TCM treatment].
    Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Feb; 17(1):30-5. PubMed ID: 7781125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on treatment of retinitis pigmentosa with traditional Chinese medicine by Flicker electroretinogram].
    Wu XW; Tang YZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Jun; 16(6):336-9. PubMed ID: 9387760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of macular oscillatory potentials in eyes of patients with retinitis pigmentosa and normal visual acuity.
    Ikenoya K; Kondo M; Piao CH; Kachi S; Miyake Y; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3312-7. PubMed ID: 17591903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photopic electroretinogram implicit time in retinitis pigmentosa.
    Iijima H; Yamaguchi S; Hosaka O
    Jpn J Ophthalmol; 1993; 37(2):130-5. PubMed ID: 8230836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photopic ERG components in retinitis pigmentosa.
    Anastasi M; Lauricella M; Ponte F
    Acta Ophthalmol (Copenh); 1992 Apr; 70(2):187-93. PubMed ID: 1609566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rod ERGs in retinitis pigmentosa and cone-rod degeneration.
    Birch DG; Fish GE
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):140-50. PubMed ID: 3804644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screen of the IMPDH1 gene among patients with dominant retinitis pigmentosa and clinical features associated with the most common mutation, Asp226Asn.
    Wada Y; Sandberg MA; McGee TL; Stillberger MA; Berson EL; Dryja TP
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1735-41. PubMed ID: 15851576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large phase differences between L-cone- and M-cone-driven electroretinograms in retinitis pigmentosa.
    Scholl HP; Kremers J
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3225-33. PubMed ID: 10967087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinitis pigmentosa and allied retinal diseases: electrophysiologic findings.
    Berson EL
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976; 81(4 Pt 1):OP659-666. PubMed ID: 960388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinitis pigmentosa and inner retina. Functional study by means of oscillatory potentials of the electroretinogram.
    Ponte F; Anastasi M; Lauricella MR
    Doc Ophthalmol; 1989 Dec; 73(4):337-46. PubMed ID: 2637116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light adaptation of the electroretinogram. Diminished in retinitis pigmentosa.
    Gouras P; MacKay CJ
    Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):619-24. PubMed ID: 2703303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal rhythm in the human rod ERG: retinitis pigmentosa.
    Birch DG
    Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):2042-8. PubMed ID: 3679752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene.
    Jacobson SG; Buraczynska M; Milam AH; Chen C; Järvaläinen M; Fujita R; Wu W; Huang Y; Cideciyan AV; Swaroop A
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1983-97. PubMed ID: 9331262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa.
    Sandberg MA; Weigel-DiFranco C; Rosner B; Berson EL
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1693-8. PubMed ID: 8675413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
    Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rod ERG diurnal rhythm in some patients with dominant retinitis pigmentosa.
    Sandberg MA; Baruzzi CM; Hanson AH; Berson EL
    Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):494-8. PubMed ID: 3343106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic effects of the Q64ter rhodopsin mutation in retinitis pigmentosa.
    Milam AH; Li ZY; Cideciyan AV; Jacobson SG
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):753-65. PubMed ID: 8603860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.